The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy

Greene, 2017, Circular RNAs: biogenesis, function and role in human diseases, Front Mol Biosci, 4, 38, 10.3389/fmolb.2017.00038

Patil, 2014, Gene regulation by non-coding RNAs, Crit Rev Biochem Mol Biol, 49, 16, 10.3109/10409238.2013.844092

Atianand, 2014, Long non-coding RNAs and control of gene expression in the immune system, Trends Mol Med, 20, 623, 10.1016/j.molmed.2014.09.002

Esteller, 2011, Non-coding RNAs in human disease, Nat Rev Genet, 12, 861, 10.1038/nrg3074

Sanger, 1976, Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures, Proc Natl Acad Sci U S A, 73, 3852, 10.1073/pnas.73.11.3852

Jeck, 2013, Circular RNAs are abundant, conserved, and associated with ALU repeats, RNA, 19, 141, 10.1261/rna.035667.112

Hansen, 2013, Natural RNA circles function as efficient microRNA sponges, Nature, 495, 384, 10.1038/nature11993

Zheng, 2016, Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs, Nat Commun, 7, 11215, 10.1038/ncomms11215

Kulcheski, 2016, Circular RNAs are miRNA sponges and can be used as a new class of biomarker, J Biotechnol, 238, 42, 10.1016/j.jbiotec.2016.09.011

Yang, 2017, Extensive translation of circular RNAs driven by N6-methyladenosine, Cell Res, 27, 626, 10.1038/cr.2017.31

Pamudurti, 2017, Translation of CircRNAs, Mol Cell, 66, 9, 10.1016/j.molcel.2017.02.021

Legnini, 2017, Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis, Mol Cell, 66, 22, 10.1016/j.molcel.2017.02.017

Yang, 2017, Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis, J Natl Cancer Inst, 110, 10.1093/jnci/djx166

Du, 2016, Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2, Nucleic Acids Res, 44, 2846, 10.1093/nar/gkw027

Abdelmohsen, 2017, Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1, RNA Biol, 14, 361, 10.1080/15476286.2017.1279788

Holdt, 2016, Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans, Nat Commun, 7, 12429, 10.1038/ncomms12429

Du, 2017, Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity, Cell Death Differ, 24, 357, 10.1038/cdd.2016.133

Li, 2015, Exon-intron circular RNAs regulate transcription in the nucleus, Nat Struct Mol Biol, 22, 256, 10.1038/nsmb.2959

Lu, 2016, Mini review: circular RNAs as potential clinical biomarkers for disorders in the central nervous system, Front Genet, 7, 53, 10.3389/fgene.2016.00053

Rybak-Wolf, 2015, Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed, Mol Cell, 58, 870, 10.1016/j.molcel.2015.03.027

Wang, 2016, Circular RNAs as potential biomarkers for cancer diagnosis and therapy, Am J Cancer Res, 6, 1167

Li, 2015, Circular RNAs in cancer: novel insights into origins, properties, functions and implications, Am J Cancer Res, 5, 472

Anastasiadou, 2018, Non-coding RNA networks in cancer, Nat Rev Cancer, 18, 5, 10.1038/nrc.2017.99

Li, 2016, Circular RNAs and systemic lupus erythematosus, Exp Cell Res, 346, 248, 10.1016/j.yexcr.2016.07.021

Cardamone, 2017, The characterization of GSDMB splicing and backsplicing profiles identifies novel isoforms and a circular RNA that are dysregulated in multiple sclerosis, Int J Mol Sci, 18, E576, 10.3390/ijms18030576

Starnes, 1992, Coley’s toxins in perspective, Nature, 357, 11, 10.1038/357011a0

Alatrash, 2013, Cancer immunotherapies, their safety and toxicity, Expert Opin Drug Saf, 12, 631, 10.1517/14740338.2013.795944

Anestakis, 2015, Mechanisms and applications of interleukins in cancer immunotherapy, Int J Mol Sci, 16, 1691, 10.3390/ijms16011691

Jasinski-Bergner, 2014, The role of microRNAs in the control of innate immune response in cancer, J Natl Cancer Inst, 106, dju257, 10.1093/jnci/dju257

Sehouli, 2014, Epigenetic quantification of tumor-infiltrating T-lymphocytes, Epigenetics, 6, 236, 10.4161/epi.6.2.13755

Peng, 2015, Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy, Nature, 527, 249, 10.1038/nature15520

Nagarsheth, 2016, PRC2 epigenetically silences Th1-type chemokines to suppress effector T-cell trafficking in colon cancer, Cancer Res, 76, 275, 10.1158/0008-5472.CAN-15-1938

Slavik, 1999, CD28/CTLA-4 and CD80/CD86 families: signaling and function, Immunol Res, 19, 1, 10.1007/BF02786473

Freeman, 1993, Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice, Science, 262, 907, 10.1126/science.7694362

Freeman, 1993, Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation, Science, 262, 909, 10.1126/science.7694363

Boussiotis, 2014, Biochemical signaling of PD-1 on T cells and its functional implications, Cancer J, 20, 265, 10.1097/PPO.0000000000000059

Chang, 2015, Metabolic competition in the tumor microenvironment is a driver of cancer progression, Cell, 162, 1229, 10.1016/j.cell.2015.08.016

Kroesen, 2015, Immuno-miRs: critical regulators of T-cell development, function and ageing, Immunology, 144, 1, 10.1111/imm.12367

Zhang, 2014, Microenvironmental regulation of cancer metastasis by miRNAs, Trends Cell Biol, 24, 153, 10.1016/j.tcb.2013.09.007

Yang, 2017, MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR, Int J Cancer, 141, 2082, 10.1002/ijc.30912

Sakurai, 2011, Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells, Int J Oncol, 39, 665, 10.3892/ijo.2011.1084

Xie, 2014, Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression, Cell Mol Immunol, 11, 495, 10.1038/cmi.2014.30

Xiang, 2016, MicroRNA-487b is a negative regulator of macrophage activation by targeting IL-33 production, J Immunol, 196, 3421, 10.4049/jimmunol.1502081

Wu, 2015, MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice, Blood, 126, 1314, 10.1182/blood-2015-02-627356

Ye, 2014, Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma, Oncotarget, 5, 5439, 10.18632/oncotarget.2118

Yin, 2014, Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth, Cell Res, 24, 1164, 10.1038/cr.2014.121

Guttman, 2013, Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins, Cell, 154, 240, 10.1016/j.cell.2013.06.009

Fitzgerald, 2014, Long noncoding RNAs in innate and adaptive immunity, Curr Opin Immunol, 26, 140, 10.1016/j.coi.2013.12.001

Zhu, 2013, Function of lncRNAs and approaches to lncRNA-protein interactions, Sci China Life Sci, 56, 876, 10.1007/s11427-013-4553-6

Pagani, 2013, Role of microRNAs and long-non-coding RNAs in CD4(+) T-cell differentiation, Immunol Rev, 253, 82, 10.1111/imr.12055

Carpenter, 2013, A long noncoding RNA mediates both activation and repression of immune response genes, Science, 341, 789, 10.1126/science.1240925

Liang, 2015, The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer, Oncotarget, 6, 22513, 10.18632/oncotarget.4154

Spurlock, 2015, Expression and functions of long noncoding RNAs during human T helper cell differentiation, Nat Commun, 6, 6932, 10.1038/ncomms7932

Hu, 2013, Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation, Nat Immunol, 14, 1190, 10.1038/ni.2712

Wang, 2015, Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection, Proc Natl Acad Sci U S A, 112, E3883, 10.1073/pnas.1501662112

Huang, 2015, DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions, Nature, 528, 517, 10.1038/nature16193

Xia, 2017, Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity, Nat Commun, 8, 15818, 10.1038/ncomms15818

Brazao, 2016, Long noncoding RNAs in B-cell development and activation, Blood, 128, e10, 10.1182/blood-2015-11-680843

Trimarchi, 2014, Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia, Cell, 158, 593, 10.1016/j.cell.2014.05.049

Wang, 2015, LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia, Sci Rep, 5, 13749, 10.1038/srep13749

Yang, 2015, Cancer immunotherapy: harnessing the immune system to battle cancer, J Clin Invest, 125, 3335, 10.1172/JCI83871

Fukuhara, 2016, Oncolytic virus therapy: a new era of cancer treatment at dawn, Cancer Sci, 107, 1373, 10.1111/cas.13027

Kalos, 2013, Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology, Immunity, 39, 49, 10.1016/j.immuni.2013.07.002

Liu, 2017, Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity, Leukemia, 10.1038/leu.2017.226

Xia, 2017, Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities, Oncotarget, 8, 90521, 10.18632/oncotarget.19361

Luo, 2012, Conservation and evolution of microRNAs in animals, Scientia Sinica Vitae, 42, 96, 10.1360/052011-594

Mahoney, 2015, The next immune-checkpoint inhibitors: PD-1/PD-L1 blockade in melanoma, Clin Ther, 37, 764, 10.1016/j.clinthera.2015.02.018

Sharon, 2014, Immune checkpoint inhibitors in clinical trials, Chin J Cancer, 33, 434, 10.5732/cjc.014.10122

Merck Provides Update on KEYNOTE-061, a Phase 3 Study of KEYTRUDA2017

Carbone, 2017, First-line nivolumab in stage IV or recurrent non-small-cell lung cancer, N Engl J Med, 376, 2415, 10.1056/NEJMoa1613493

Merck Provides Further Update on Tree Multiple Myeloma Studies Evaluating KEYTRUDA? (pembrolizumab) in Combination with Pomalidomide or Lenalidomide2017

Azoury, 2015, Immune checkpoint inhibitors for cancer therapy: clinical efficacy and safety, Curr Cancer Drug Targets, 15, 452, 10.2174/156800961506150805145120

Wei, 2016, MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints, Neuro Oncol, 18, 639, 10.1093/neuonc/nov292

Cortez, 2016, PDL1 regulation by p53 via miR-34, J Natl Cancer Inst, 108, djv303, 10.1093/jnci/djv303

Butterfield, 2015, Cancer vaccines, BMJ, 350, h988, 10.1136/bmj.h988

Cintolo, 2012, Dendritic cell-based vaccines: barriers and opportunities, Future Oncol, 8, 1273, 10.2217/fon.12.125

Kaufman, 2015, Oncolytic viruses: a new class of immunotherapy drugs, Nat Rev Drug Discov, 14, 642, 10.1038/nrd4663

Dharmadhikari, 2015, Oncolytic virus immunotherapy for melanoma, Curr Treat Options Oncol, 16, 326, 10.1007/s11864-014-0326-0

Ruiz, 2015, MicroRNAs and oncolytic viruses, Curr Opin Virol, 13, 40, 10.1016/j.coviro.2015.03.007

Serganova, 2017, Enhancement of PSMA-directed CAR adoptive immunotherapy by PD-1/PD-L1 blockade, Mol Ther Oncolytics, 4, 41, 10.1016/j.omto.2016.11.005

Soares, 2015, PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors, J Immunother, 38, 1, 10.1097/CJI.0000000000000062

Liu, 2017, Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy, Nat Commun, 8, 14754, 10.1038/ncomms14754

Meng, 2017, CircRNA: functions and properties of a novel potential biomarker for cancer, Mol Cancer, 16, 94, 10.1186/s12943-017-0663-2

Hsiao, 2017, Circular RNA – new member of noncoding RNA with novel functions, Exp Biol Med (Maywood), 242, 1136, 10.1177/1535370217708978

Liu, 2017, Circles reshaping the RNA world: from waste to treasure, Mol Cancer, 16, 58, 10.1186/s12943-017-0630-y

Tang, 2017, Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7, Onco Targets Ther, 10, 2045, 10.2147/OTT.S131597

Xu, 2017, The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma, J Cancer Res Clin Oncol, 143, 17, 10.1007/s00432-016-2256-7

Xu, 2015, The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells, Sci Rep, 5, 12453, 10.1038/srep12453

Han, 2017, Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression, Hepatology, 66, 1151, 10.1002/hep.29270

Peng, 2017, Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease, Oncotarget, 8, 808, 10.18632/oncotarget.13656

Yu, 2017, The circular RNA circBIRC6 participates in the molecular circuitry controlling human pluripotency, Nat Commun, 8, 1149, 10.1038/s41467-017-01216-w

Zeng, 2017, A circular RNA binds to and activates AKT phosphorylation and nuclear localization reducing apoptosis and enhancing cardiac repair, Theranostics, 7, 3842, 10.7150/thno.19764

Zhang, 2013, Circular intronic long noncoding RNAs, Mol Cell, 51, 792, 10.1016/j.molcel.2013.08.017

Yang, 2017, The circular RNA interacts with STAT3, increasing its nuclear translocation and wound repair by modulating Dnmt3a and miR-17 function, Mol Ther, 25, 2062, 10.1016/j.ymthe.2017.05.022

Yang, 2017, A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation, Cell Death Differ, 24, 1609, 10.1038/cdd.2017.86

Ng, 2016, Inducible RasGEF1B circular RNA is a positive regulator of ICAM-1 in the TLR4/LPS pathway, RNA Biol, 13, 861, 10.1080/15476286.2016.1207036

Conn, 2017, A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation, Nat Plants, 3, 17053, 10.1038/nplants.2017.53

Li, 2015, Using circular RNA as a novel type of biomarker in the screening of gastric cancer, Clin Chim Acta, 444, 132, 10.1016/j.cca.2015.02.018

Xuan, 2016, Circular RNA: a novel biomarker for progressive laryngeal cancer, Am J Transl Res, 8, 932

Zhang, 2017, Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR-138 targets TERT and PD-L1, Cell Biol Int, 41, 1056, 10.1002/cbin.10826

Huang, 2014, p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation, Oncogene, 33, 3830, 10.1038/onc.2013.355

Cadena, 2017, Antiviral immunity and circular RNA: no end in sight, Mol Cell, 67, 163, 10.1016/j.molcel.2017.07.005

Guarnerio, 2016, Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations, Cell, 165, 289, 10.1016/j.cell.2016.03.020

Dou, 2016, Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes, Sci Rep, 6, 37982, 10.1038/srep37982

Li, 2016, New insights into regulatory T cells: exosome- and non-coding RNA-mediated regulation of homeostasis and resident Treg cells, Front Immunol, 7, 574, 10.3389/fimmu.2016.00574

Lasda, 2016, Circular RNAs co-precipitate with extracellular vesicles: a possible mechanism for circRNA clearance, PLoS One, 11, e0148407, 10.1371/journal.pone.0148407

Li, 2017, Coordinated circRNA biogenesis and function with NF90/NF110 in viral infection, Mol Cell, 67, 214, 10.1016/j.molcel.2017.05.023

Milane, 2015, Exosome mediated communication within the tumor microenvironment, J Control Release, 219, 278, 10.1016/j.jconrel.2015.06.029

Nabet, 2017, Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer, Cell, 170, 352, 10.1016/j.cell.2017.06.031

Chen, 2017, Sensing self and foreign circular RNAs by intron identity, Mol Cell, 67, 228, 10.1016/j.molcel.2017.05.022